Clinical Trial Update: A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating CUSP9v3, a combination of 9 repurposed drugs with metronomic temozolomide, in recurrent glioblastoma; study status complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• CUSP9v3
• Temozolomide (Temozolomide)

Snippet

Sponsor: University of Ulm | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: COMPLETED